purpose
Previously published guidelines are available that provide comprehensive recommendations for detecting and preventing healthcare-associated infections (HAIs). The intent of this document is to highlight practical recommendations in a concise format designed to assist acute care hospitals in implementing and prioritizing their central line-associated bloodstream infection (CLABSI) prevention efforts. This document updates "Strategies to Prevent Central Line-Associated Bloodstream Infections in Acute Care Hospitals," 1 published in 2008. This expert guidance document is sponsored by the Society for Healthcare Epidemiology of America (SHEA) and is the product of a collaborative effort led by SHEA, the Infectious Diseases Society of America (IDSA), the American Hospital Association (AHA), the Association for Professionals in Infection Control and Epidemiology (APIC), and The Joint Commission, with major contributions from representatives of a number of organizations and societies with content expertise. The list of endorsing and supporting organizations is presented in the introduction to the 2014 updates. 2 section 1: rationale and statements of concern I. Patients at risk for CLABSIs in acute care facilities A. Intensive care unit (ICU) population: the risk of CLABSI in ICU patients is high. Reasons for this include the frequent insertion of multiple catheters, the use of specific types of catheters that are almost exclusively inserted in ICU patients and associated with substantial risk (eg, pulmonary artery catheters with catheter introducers), and the fact that catheters are frequently placed in emergency circumstances, repeatedly accessed each day, and often needed for extended periods of time.
3,4
B. Non-ICU population: although the primary focus of attention over the last 2 decades has been the ICU setting, the majority of CLABSIs occur in hospital units outside the ICU or in outpatients.
5-10 C. Infection prevention and control efforts should include other vulnerable populations, such as patients receiving hemodialysis through catheters, 11 intraoperative patients, 12 and oncology patients. D. Besides central venous catheters (CVCs), peripheral arterial catheters also carry a risk of infection.
3
II. Outcomes associated with hospital-acquired CLABSI A. Increased length of hospital stay. [13] [14] [15] [16] [17] B. Increased cost (the non-inflation-adjusted attributable cost of CLABSIs has been found to vary from $3,700 to $39,000 per episode 14, [17] [18] [19] ). III. Independent risk factors for CLABSI (in at least 2 published studies) [20] [21] [22] [23] [24] [25] A. Factors associated with increased risk. 1. Prolonged hospitalization before catheterization 2. Prolonged duration of catheterization 3. Heavy microbial colonization at the insertion site 4. Heavy microbial colonization of the catheter hub 5. Internal jugular catheterization 6. Femoral catheterization in adults 7. Neutropenia 8. Prematurity (ie, early gestational age) 9. Reduced nurse-to-patient ratio in the ICU 26, 27 10. Total parenteral nutrition 11. Substandard catheter care (eg, excessive manipulation of the catheter) 12. Transfusion of blood products (in children) B. Factors associated with reduced risk.
1. Female sex 2. Antibiotic administration 22, 28 3. Minocycline-rifampin-impregnated catheters 29, 30 section 2: background-strategies to detect clabsi 1. Recent data suggest that interrater reliability using NHSN definitions is lower than expected. [32] [33] [34] This may also affect the reliability of public reporting. Additionally, the NHSN surveillance definition for CLABSI is different from the clinical definition for catheterrelated bloodstream infection. These can be implemented in specific locations or patient populations or can be implemented hospital-wide, depending on outcome data, risk assessment, and/or local requirements. Each infection prevention recommendation is given a quality-of-evidence grade (see Table 1 ). Note that some of the following measures have been combined into a "prevention bundle" that focuses on catheter insertion (eg, measures B.2, B.3, B.6, B.7, and C.3). [44] [45] [46] Numerous studies have documented that use of such bundles is effective, sustainable, and cost-effective in both adults and children. [47] [48] [49] [50] Bundles are most likely to be successful if implemented in a previously established patient safety culture, and their success depends on adherence to individual mea- I. High Highly confident that the true effect lies close to that of the estimated size and direction of the effect. Evidence is rated as high quality when there is a wide range of studies with no major limitations, there is little variation between studies, and the summary estimate has a narrow confidence interval. II. Moderate The true effect is likely to be close to the estimated size and direction of the effect, but there is a possibility that it is substantially different. Evidence is rated as moderate quality when there are only a few studies and some have limitations but not major flaws, there is some variation between studies, or the confidence interval of the summary estimate is wide.
III. Low
The true effect may be substantially different from the estimated size and direction of the effect. Evidence is rated as low quality when supporting studies have major flaws, there is important variation between studies, the confidence interval of the summary estimate is very wide, or there are no rigorous studies, only expert consensus.
note. Based on Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) 257 and the Canadian Task Force on Preventive Health Care. 258 sures. 51 However, recent data suggest that not all components of bundles may be necessary to achieve an effect on CLABSI rates. 52 After catheter insertion, maintenance bundles have been proposed to ensure optimal catheter care. 53 More data are needed to determine which components of the maintenance bundle are essential in reducing risk. a. Before accessing catheter hubs, needleless connectors, or injection ports, vigorously apply mechanical friction with an alcoholic chlorhexidine preparation, 70% alcohol, or povidone-iodine. Alcoholic chlorhexidine may have additional residual activity compared with alcohol for this purpose. b. Apply mechanical friction for no less than 5 seconds to reduce contamination. 121, 122 It is unclear whether this duration of disinfection can be generalized to needleless connectors not tested in these studies. a. The optimal replacement intervals of intermittently used administration sets are currently unresolved. 6. Use antimicrobial ointments for hemodialysis catheter-insertion sites (quality of evidence: I). [134] [135] [136] [137] [138] [139] [140] a. Polysporin "triple" (where available) or povidoneiodine ointment should be applied to hemodialysis catheter insertion if compatible with the catheter material. i. Certain manufacturers have indicated that the glycol constituents of ointments should not be used on their polyurethane catheters. b. Mupirocin ointment should not be applied to the catheter-insertion site due to the risks of facilitating mupirocin resistance and the potential damage to polyurethane catheters. 7. Perform surveillance for CLABSI in ICU and non-ICU settings (quality of evidence: I).
6,7,141,142
a. Measure the unit-specific incidence of CLABSI (CLABSIs per 1,000 catheter-days) and report the data on a regular basis to the units, physician and nursing leadership, and hospital administrators overseeing the units. b. Compare CLABSI incidence with historical data for individual units and with national rates (ie, NHSN 143 ). c. Audit surveillance as necessary to minimize variation in interobserver reliability. 32, 33 d. Surveillance for CLABSI outside the ICU setting requires additional resources. 144 Electronic surveillance is an option in these settings. 145 
II. Special approaches for preventing CLABSI
A number of special approaches are currently available for use. Perform a CLABSI risk assessment before considering implementing any of these approaches, and take potential adverse events and cost into consideration. Although it is reasonable to evaluate the utility of technology-based interventions when CLABSI rates are above the institutional or unit-based threshold, this is also an opportunity to review practices and consider behavioral changes that may be instituted to reduce CLABSI risk. These special approaches are recommended for use in locations and/or populations within the hospital with unacceptably high CLABSI rates despite implementation of the basic CLABSI prevention strategies listed above. These measures may not be indicated if institutional goals have been consistently achieved.
Use antiseptic-or antimicrobial-impregnated CVCs in
adult patients (quality of evidence: I). a. It is unclear whether there is additional benefit to using a chlorhexidine-containing dressing if daily chlorhexidine bathing is already established and vice versa. 3. Use an antiseptic-containing hub/connector cap/port protector to cover connectors (quality of evidence: I). [161] [162] [163] [164] [165] 4. Use silver zeolite-impregnated umbilical catheters in preterm infants (in countries where it is approved for use in children; quality of evidence: II). 166 a. Observational studies suggest that other antimicrobial-impregnated catheters appear to be safe and hold promise in pediatric ICU patients. [167] [168] [169] 5. Use antimicrobial locks for CVCs (quality of evidence: I). 203 7. Impact of the use of chlorhexidine-based products on bacterial resistance to chlorhexidine. a. Widespread use of chlorhexidine-based products (eg, use of chlorhexidine bathing, antisepsis, and dressings) may promote reduced chlorhexidine susceptibility in bacterial strains. 204 However, testing for chlorhexidine susceptibility is not standardized. The clinical impact of reduced chlorhexidine susceptibility in gram-negative bacteria is unknown. Accountability is an essential principle for preventing HAIs. It provides the necessary translational link between science and implementation. Without clear accountability, scientifically based implementation strategies will be used in an inconsistent and fragmented way, decreasing their effectiveness in preventing HAIs. Accountability begins with the chief executive officer and other senior leaders who provide the imperative for HAI prevention, thereby making HAI prevention an organizational priority. Senior leadership is accountable for providing adequate resources needed for effective implementation of an HAI prevention program. These resources include necessary personnel (clinical and nonclinical), education, and equipment (Table 2) . Insertion of CVCs is one of the most common procedures performed at the patient's bedside. The insertion procedure represents only one aspect of the risk for CLABSI, with the risk extending to all aspects of nursing care and maintenance during the CVC dwell time. CLABSI prevention strategies have expanded as new studies are published. Additionally, experience with implementing these strategies is increasing. This discussion will focus on strategies for engagement, education, execution, and evaluation of CLABSI prevention efforts. Published literature and expert opinion form the basis for the following recommendations.
I. Engage
The first step toward successful reduction of CLABSIs is to engage both frontline and senior leadership champions in the process and outcome improvement plan. 215 A. Develop a multidisciplinary team that sets goals, defines the steps in the implementation process, and monitors Senior management is responsible for ensuring that the healthcare system supports an infection prevention and control (IPC) program that effectively prevents healthcare-associated infections (HAIs) and the transmission of epidemiologically important pathogens Senior management is accountable for ensuring that an adequate number of trained personnel are assigned to the IPC program and adequate staffing of other departments that play a key role in HAI prevention (eg, environmental services) Senior management is accountable for ensuring that healthcare personnel, including licensed and nonlicensed personnel, are adequately trained and competent to perform their job responsibilities Direct healthcare providers (such as physicians, nurses, aides, and therapists) and ancillary personnel (such as environmental service and equipment processing personnel) are responsible for ensuring that appropriate IPC practices are used at all times (including hand hygiene, standard and isolation precautions, and cleaning and disinfection of equipment and the environment) Senior and unit leaders are responsible for holding personnel accountable for their actions IPC leadership is responsible for ensuring that an active program to identify HAIs is implemented, that HAI data are analyzed and regularly provided to those who can use the information to improve the quality of care (eg, unit staff, clinicians, and hospital administrators), and that evidence-based practices are incorporated into the program Senior and unit leaders are accountable for ensuring that appropriate training and educational programs to prevent HAIs are developed and provided to personnel, patients, and families Personnel from the IPC program, the laboratory, and information technology departments are responsible for ensuring that systems are in place to support the surveillance program progress in achieving the goals. Regular team meetings should be held.
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B. Focus on a culture of safety, which includes teamwork, technical processes, and promotion of accountability for prevention of CLABSI. C. Make the problem real to all of those involved to increase buy-in. One strategy to accomplish this is to identify a patient in the unit who has suffered harm as a result of developing a CLABSI 217 and then share that story with the team. D. Identify and involve local champions. Engage infusion nurses or vascular access specialists as team members. Include formal (eg, medical or nursing directors, charge nurses) and informal (eg, frontline) leaders. 218 Local champions increase the chance for success by engaging and educating peers, thereby increasing buy-in and ownership by all involved. 215 These champions can influence the development of strategies that are a good match with the unit culture. Frequent communication between champions and frontline staff is imperative if concerns are to be resolved and improvement sustained. 215 E. Share the outcome data regularly with each unit. Data can be represented as the monthly CLABSI rate and/or the number of days since last infection. 217 Consider reporting CLABSI rates as the standardized infection ratio (SIR). Displaying a trend line is also useful. F. Utilize peer networks. Voluntary peer networking between hospitals can promote and ensure compliance with evidence-based practices. It also facilitates collaboration, performance evaluation, and accountability. All can benefit from best practices being shared, and brainstorming can be done to solve shared problems. 219 II. Educate A. Change in human behavior is the goal of educational programs about CVC insertion, care, and maintenance.
Various educational methods and strategies have been studied to reduce CLABSI. In general, these educational interventions showed improvements in CLABSI rates; however, more study is needed to clearly understand the most effective teaching strategies, content taught, length of presentation, and frequency for repeating the program. 220, 221 Both extraluminal and intraluminal avenues for CVC infection should be addressed in the educational plan. B. Educational programs for all healthcare personnel involved with the insertion and care of all types of CVCs should address knowledge, critical thinking, behavior and psychomotor skills, and attitudes and beliefs. Identifying and analyzing gaps in these areas leads to the selection of measureable learning objectives, course content, and corresponding appropriate teaching strategies. The value of infection prevention should be emphasized through all education efforts. 221, 222 C. Adult learners employ multiple ways to learn; therefore, multiple teaching strategies should be used. This includes self-directed study guides, instructor-led courses, and small-and large-group discussions. The planning group for the educational offering should have representatives from multiple professions, including physicians, nurse managers, staff nurses, infusion nurse specialists, and infection preventionists. [223] [224] [225] The learner should be actively involved with the teaching methods, as lecture alone has been shown to be less effective with retention of information and changes in behavior. 226, 227 Delivery methods should be chosen on the basis of the learners' needs and availability, along with the technical capabilities of the facility. This includes printed learning packages; audiovisual formats, such as slide presentations and videos; skills labs; journal clubs and nursing grand rounds; and computer-, Internet-, or DVD-based packages of learning materials.
58,224,228-231 Multiple delivery methods tailored to specific problems or issues and given intermittently over time produce greater reduction in CLABSI than a single structured offering or lecture. 61, 232 D. Other educational job aides should be readily accessible in the clinical setting for quick reminders and reinforcement of the appropriate procedures. This includes but is not limited to facility policies and procedures, posters, fact sheets, small pocket cards, e-mail messages, and messages via computer screen savers. 233, 234 E. To enhance patient safety, learning CVC insertion techniques requires a structured educational program focusing on knowledge acquisition and performance of insertions in a simulated environment, followed by supervised performance on patients. 43,235-237 A meta-analysis of 20 studies using simulation for CVC insertion showed benefits in learner performance, knowledge, and confidence. 66 Simulation for CVC insertion includes use of anatomical models and computer-based virtual reality. 238 Other approaches have tried to simulate the "feel" of tissue puncture. 239 F. All healthcare professionals should have documented competency with CVC insertion, care, and maintenance before being allowed to practice without direct supervision. A standardized competency assessment checklist should be used to assess and document competency of each individual performing CVC insertion and procedures related to care and maintenance (eg, dressing changes). Competency assessment checklists should be evaluated for interrater reliability and validity. The professional performing competency assessment of the learner should be competent with the procedure being assessed. 220, 240 G. Changes of products, devices, or technology used in the insertion and care of CVCs require adequate device training for all healthcare personnel expected to use the product(s). This training follows a period of device evaluation and its impact on CLABSI. Most device manufacturers employ personnel with clinical experience to provide product training, and this resource should not be overlooked. H. Healthcare professionals using CVCs for infusion should have documented competency with all procedures, including but not limited to catheter stabilization, catheter dressing changes, intravenous administration set management, disinfection of needleless connectors, accessing implanted ports, and flushing and locking the CVC. 43 This would involve demonstration of procedures in a simulation lab or in the clinical setting while being observed by a qualified professional. 241, 242 I. Assessment of educational programs includes the learner's satisfaction with the program, changes in knowledge, and changes in work performance. Written tests are the most common form of measurement; however, this is limited to knowledge acquisition only and may produce anxiety in many adult learners. Other forms of assessment include contributions to group discussions and observation of performance using simulation. Measurement of healthcare professionals' current level of knowledge about CVC insertion and care can provide valuable information for designing educational programs. 243, 244 J. Prior to an educational program, there should be planning for transfer of the learning from the classroom to the clinical setting. This includes patient care assignments to allow for application of new knowledge and practice of new skills, support and encouragement from leaders and managers, and the ability to follow up on issues or concerns that arise from clinical performance. K. Education of the patient and/or family, as appropriate, is required for all CVC care procedures (eg, hand hygiene, dressing changes, intravenous administration set management, and flushing and locking), especially when transfer to an alternative setting (eg, home care, ambulatory setting) is planned. 43, 242 L. Education of facility administrators is necessary to ensure adequate funding and implementation of CLABSI prevention. 242 Additionally, the goal of zero tolerance for CLABSI may be set by the chief officers of an institution; 245 B. Evaluation involves both process and outcome measurement. 246 Differences between age groups should also be considered (eg, neonates, pediatrics, and adults). 54, 249, 250 C. Process measurement includes but is not limited to compliance with insertion bundles, CVC utilization by insertion site or type (eg, femoral catheters vs other CVC sites; PICCs vs centrally inserted lines), the condition of CVC dressing and timely dressing changes, and integrity and appropriate management of needleless connectors, other add-on devices, and intravenous administration sets. 43, 251, 252 Device utilization is defined as the number of catheter-days divided by the number of patient-days. 245 D. Establish baseline compliance with evidence-based practices for line maintenance, such as the presence of clean and intact dressings. E. Outcome measurement is the incidence rate of CLABSI and other infections associated with all types of vascular access devices (eg, exit-site infection, suppurative thrombophlebitis). Consider reporting CLABSI rates as SIR. F. Process and outcome data should be linked to initial and ongoing competency assessment. Initial competency should be assessed at employment, after orientation, and with the introduction of new equipment or technology. Ongoing competency assessment is determined by process and outcome data with the facility deciding the frequency for repeated competency assessment.
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G. Measurement of education outcomes is needed on several levels. The learner's satisfaction with the program is assessed by completion of the evaluation form immediately following completion of the program. This form also includes the learner's self-assessment of achieving the learning objectives. The next level is measuring the change in learner's knowledge, most often accomplished by comparison of scores on written preand posttests. The third level is to measure the actual change in behavior in clinical practice following the completion of the program. Using only the first and second levels of measurement will not ensure that a change in clinical behavior will occur.
Numerous factors affect CLABSI surveillance, including CVC type, CLABSI definition, blood culturing practices and written policies, laboratory practices, and staff attitudes and beliefs. Standardization of these factors facilitates benchmarking within and between organizations. Additionally, variations in these determinants could impact publicly reported CLABSI rates and influence reimbursement for hospital-acquired conditions. 32, 247 H. Surveillance for CLABSI outside the ICU is becoming more prevalent, especially with increasing use of electronic methods for data collection. 253, 254 I. Feedback to all healthcare staff is critical for the success of any evaluation program. Unit-based recognition of achievement of low CLABSI rates or the length of time between CLABSI events is a useful method to encourage staff involvement. The goals for improvement should be clearly and frequently articulated. Audit compliance with completion of insertion checklists and share this data with the staff. Other forms of feedback include periodic (eg, monthly, quarterly) communication (eg, e-mail messages, written reports) of process measurement data: posters, reports, or other forms of communication with graphs showing cumulative compliance with process measures. 
